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Abstract
African American men have the highest prostate cancer-related mortality nationally. In response to this disparity,
targeted interventions are emerging to enhance African American men’s prostate cancer (PrCA) knowledge to ensure
they are equipped to make informed decisions about PrCA screening with health-care providers. African American
men’s PrCA knowledge has been measured inconsistently over time with limited psychometric evidence. The factor
structure of this construct in African American men is relatively unknown. This study describes the development
and psychometric evaluation of an 18-item Prostate Cancer Knowledge Scale among 352 African American men.
Exploratory factor analysis (EFA) was conducted using weighted least square mean and variance estimation with
Geomin rotation. EFA yielded three factors: PrCA Anatomy and Screening (6 items), Risk Factors (5 items), Warning Signs
(7 items) with good internal consistency reliability at KR-20 = .80 for the total scale and .64, .66, and .75, respectively,
for each subscale. Factor loadings ranged from .31 to .86. The standardized root mean square residual (0.08) indicated
that the factor structure explained most of the correlations. The three-factor, 18-item Prostate Cancer Knowledge
Scale demonstrates that PrCA knowledge is a multidimensional construct and has utility for reliably measuring PrCA
knowledge among African American men. Future research is required to confirm this factor structure among sociodemographically diverse African Americans.
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Prostate cancer (PrCA) is the number one nonskin cancer
among men with an estimated 174,650 men who will be
diagnosed and 31,620 men who will die from the disease in
2019 (Siegel et al., 2019). African American men have
PrCA morbidity and mortality at more than two times the
rate of their White counterparts (Siegel et al., 2019). Myriad
factors contribute to these disparities, including health
beliefs and behaviors and having access to health care.
None of these factors have definitive associations with
PrCA morbidity or mortality (Mordukhovich et al., 2011;
Taksler et al., 2012). PrCA disparities are further complicated by the ongoing debate regarding the efficacy of the
prostate-specific antigen (PSA) screening exam (Kim &
Andriole, 2015), which led to mixed clinical recommendations from health-care providers about screening (Fleshner
et al., 2017) and an increase in patients who elect to forego

screening (Gibson et al., 2016). PrCA disparities are partly
explained by African American men’s lower PrCA knowledge (Dhillon et al., 2017; Owens et al., 2018). To reduce
the burden of PrCA, the American Cancer Society (ACS;
Wolf et al., 2010), American Urological Association (AUA;
Carter et al., 2013), and the United States Preventive
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Services Task Force (USPSTF; Bibbins-Domingo et al.,
2017) recommend that men make an informed decision
with their health-care provider about whether to receive
PrCA screening. Informed decision-making is when an
individual understands a disease as well as risks, benefits,
uncertainties, and alternatives to screening and is involved
in the decision-making process to the extent that he or she
desires (Briss et al., 2004). Based on this definition, many
researchers identify knowledge as critical to informed decision-making (Mullen et al., 2006). PrCA knowledge is a
focal point for PrCA interventions promoting informed
decision-making (Ilic et al., 2015; Riikonen et al., 2018).
PrCA knowledge has been measured inconsistently over
time with limited psychometric evidence, particularly
among African Americans, which limits generalizability
across studies. Below is a review of measures used to assess
PrCA knowledge among African American men.

A Review of Prostate Cancer
Knowledge Measures
The Knowledge and Attitude Survey (Demark-Wahnefried
et al., 1993, 1995) is a 24-item, multiple-choice questionnaire that assesses PrCA knowledge and beliefs. Scoring
was based on the percentage of questions answered correctly. After administration of the Knowledge and Attitude
Survey to 286 African American and White men in nine
PrCA Awareness screening events in the southeastern
United States, Denmark-Wahnefried et al. (1993, 1995)
discovered that African American men were less likely to
(a) have a regular doctor, (b) ever have a digital rectal
examination (DRE) or PSA test, (c) report that a man with
PrCA can lead a normal life, or (d) that men can have
PrCA without symptoms. A substantial number of both
African American and White men did not know race and/
or heredity are risk factors for PrCA, although this number
was higher in African American men (Demark-Wahnefried
et al., 1993, 1995). No psychometric properties were
reported for this scale (Demark-Wahnefried et al., 1993,
1995).
The Prostate Cancer Knowledge Inventory (Boehm
et al., 1995) is a 11-item questionnaire designed to assess
African American men’s PrCA knowledge and screening
behaviors. Response categories for each item is true–
false. Scores range from 0 to 11 (correct or incorrect) with
higher scores indicating higher PrCA knowledge. When
administered as part of a PrCA education and screening
program in African American churches, the internal consistency reliability using the Kuder–Richardson Formula
20 (KR-20) at pretest and posttest in a subsample of
African American men (n = 123) was .45 and .58, respectively (Boehm et al., 1995). Content and face validity
were enhanced by a literature review, clinician’s expert
review, and focus groups with African American men.
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Smith et al. (1997) asked 556 African American men
seven questions about PrCA knowledge (e.g., risk factors) based on measures developed by Boehm et al.
(1995) and Demark-Wahnefried et al. (1995). Responses
were grouped by low, medium, and high PrCA knowledge
categories based on the number of correct items. Similar
to prior studies, Smith et al. (1997) reported African
American men’s PrCA knowledge was inadequate. No
internal consistency reliability was reported for the scale.
Abbott et al. (1998) used a pretest–posttest design to
compare PrCA knowledge in African American (n = 388)
and Caucasian (n = 566) men (N = 944) as a part of a PrCA
screening and education intervention in a senior health
clinic. An unspecified number of questionnaire items measured three constructs: (a) etiology, (b) risk factors, and (c)
clinical factors. The total score for the full questionnaire is
7. PrCA knowledge increased overall following the intervention. However, African American men were less likely
than Caucasian men to correctly identify early symptoms of
PrCA and the basic components of prostate screening. In
the same sample, this questionnaire was used to evaluate
the effectiveness of an educational PrCA screening program and identified that African American men had lower
levels of knowledge about prostate etiology and clinical
factors (Barber et al., 1998). No psychometric properties of
the questionnaire used in studies by Abbott et al (1998) or
Barber et al. (1998) were reported.
The Knowledge of Prostate Cancer Screening
Questionnaire (Weinrich et al., 1998) is a six-item questionnaire developed to assess men’s knowledge about
PrCA screening, symptoms, and risk factors. This questionnaire was developed by interviewing 99 primarily
low-income African American men about their existing
PrCA knowledge. Five cancer health professionals were
used to establish content validity and the measure was
pilot tested on 17 occasions. Dichotomous responses
were agree or disagree and scores ranged from 1 to 6
based on the number of items answered correctly. After
administration to 56 men, the total score mean was 3.75
(SD = 1.5) and the reliability was 0.61. In a sample of
men (n = 319; 82% African American), Weinrich et al.
(1998) assessed PrCA knowledge prior to implementation of an educational program and discovered PrCA
knowledge predicts participation in PrCA screening.
Internal consistency reliability of the scale using
Cronbach’s α was 0.73. Content validity was established
using nine subject-matter experts and construct validity
was examined using factor analysis.
Steele et al. (2000) developed a 13-item PrCA Risks,
Knowledge, Attitudes and Screening Practices Scale to
measure self-perceived risk and knowledge, attitudes, and
screening practices of older men (≥50 years). Only 2 of
13 items on the scale measured PSA screening knowledge
and the second question assessed men’s awareness of PSA
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screening. No detailed description of the measure was
provided, including the scale’s development, response
options, and scoring. The PrCA Risks, Knowledge,
Attitudes and Screening Practices Scale was administered
via phone to two populations of men in New York: a statewide sample of 631 men (84% White) and 742 African
American men (Steele et al., 2000). African American
men were discovered somewhat less likely than White
men to recognize their higher PrCA risk and significantly
less likely to be aware of the PSA screening. No psychometric properties of this scale were reported.
To examine correlates of actual and perceived PrCA
knowledge among African American men, Agho and
Lewis (2001) developed an original questionnaire based
on recommendations from several health authorities (e.g.,
ACS). The questionnaire consisted of 31 items designed
to measure actual PrCA knowledge, perceived PrCA
knowledge, use of prostate screening services, and demographic characteristics. The Actual Prostate Knowledge
Scale (Agho & Lewis, 2001) was a 21-item self-report
measure designed to determine African American men’s
factual PrCA knowledge and was similar to PrCA knowledge scales developed prior to 2001 (see measures
reviewed above). The Perceived Prostate Cancer
Knowledge Scale (Agho & Lewis, 2001) was developed
to measure participants’ subjective PrCA knowledge
(e.g., I am very knowledgeable about PrCA). The authors
do not report the number of items on this scale.
Dichotomized responses of both scales were true–false
and scored based on the percentage of correct items. In a
convenience sample of 108 African American men in
Florida, the men had low PrCA knowledge, actual and
perceived PrCA knowledge were positively correlated,
and actual knowledge was negatively correlated with age
and income. Cronbach’s α for the Actual and Perceived
Prostate Knowledge Scales was .87 and .81, respectively.
Validity of the scales was not reported.
The Prostate Cancer Knowledge Scale (Wilkinson
et al., 2003) is a 12-item self-report measure developed to
assess men’s knowledge of PrCA risk factors, symptoms,
prevention, screening, and treatment. Response options
were multiple choice or true/false with each question also
including an I don’t know response option. Scoring was
based on the percentage of questions answered correctly
and ranged from 0 to 100. In a sample of 835 African
American men (n = 696) and women (n = 139), the
Prostate Cancer Knowledge Scale was used to assess the
effectiveness of a PrCA education program to improve
PrCA awareness and knowledge using a pretest–posttest
design. Women were included in the study because of
their influence on the PrCA screening decisions of
African American men. Findings identified that the education program improved PrCA knowledge. No psychometric properties of this scale were reported.
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A revised Knowledge of Prostate Cancer Screening
Questionnaire (Weinrich et al., 2004) was expanded from
6 (Weinrich et al., 1998) to 12 items, which measured
PrCA limitations, symptoms, risk factors, side effects of
PrCA treatment, and PrCA screening age guidelines.
Response options were true/false or I don’t know. Total
scores ranged from 0 to 12 based on the number of correct items. In 2002, the scale was administered to nine
men to assess face validity (Weinrich et al., 2004). In a
sample of 81 low-income men (60 African Americans, 21
Caucasians), the total mean score was 6.6 (SD = 3.0), the
median score was 7, and the internal consistency reliability using the KR-20 was 0.77 (Weinrich et al., 2004). In a
sample of 27 men, test–retest reliability using Cohen’s κ
was 0.55. Construct validity of the 12-item questionnaire
using factor analysis resulted in a unidimensional 12-item
factor structure by retaining items loading at 0.35 or
greater (Weinrich et al., 2004).
Cormier and colleagues created the PrCA Knowledge
Scale (Cormier et al., 2002) by combining 20 items from
three aforementioned scales (Boehm et al., 1995; DemarkWahnefried et al., 1995; Weinrich et al., 1998). Eleven
items were from the PrCA Knowledge Screening
Questionnaire (Weinrich et al., 2004). Six items were
from the PrCA Knowledge Inventory (Boehm et al.,
1995). Three multiple-choice items were from the
Knowledge and Attitude Survey (Weinrich et al., 1998),
which also assessed beliefs (three items on screening,
three items on treatment, one item on perceived risk).
Constructs include Prostate anatomy and function (two
items), PrCA risk factors (six items), PrCA screening
(nine items), and PrCA symptoms (four items). Response
categories for each item are true, false, and I don’t know.
Scoring was calculated by summing item scores (i.e., 1
point per correct item) for a total of 20 points (ranging
0–20). Response categories for the perceived risk item
included being less than, equal to, or more than the risk
of the average man (Cormier et al., 2002). When administered to 139 men (92% White) who were brothers and
sons of PrCA survivors, PrCA knowledge was high overall, but race as a risk factor and PrCA warning signs were
poorly understood (Cormier et al., 2002). No psychometric properties of Cormier et al.’s PrCA Knowledge Scale
were reported.
Magnus (2004) developed a five-item Prostate Cancer
Knowledge Scale with guidance from educational information released by the ACS. Items specifically focused on
risk factors for multi-ethnic African American men, contained dichotomous response options, and scored based on
the percentage of questions answered correctly. Face
validity was determined by academicians and public
health practitioners. This Prostate Cancer Knowledge
Scale was administered to 528 African American, Englishspeaking Caribbean, Haitian-American, and African men
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in the United States. Overall, PrCA knowledge among
these Black men was moderate to high with mean correct
responses at 68%. Although no significant differences in
knowledge between the ethnic groups was identified, men
with higher incomes and family histories of PrCA had the
highest knowledge scores. No psychometric properties of
the scale were reported.
Radosevich et al. (2004) developed and systematically
evaluated the reliability and validity of the PROCASE
Knowledge Index, a 10-item scale measuring PrCA history and risk factors (five items), PSA accuracy and follow-up tests (three items), and PrCA treatment efficacy
(two items). Four additional items were included that
measured knowledge of the likelihood of death from
PrCA, predictive value of PSA tests, natural history of
PrCA, and experts’ agreement on validity of the PSA test.
Response options were true/false, and two of four additional items were multiple choice. Scoring was based on
the percentage of items answered correctly. To assess
psychometric properties, the PROCASE Knowledge
Index and the four single items were administered to
1,152 male veterans (57% White), aged 50 and older.
Internal consistency reliability using the KR-20 was 0.68
and had robust construct and criterion validity. However,
the four single-item questions combined with the
PROCASE Knowledge Index had weak validity.
The Cancer Knowledge Survey, developed by Powe
et al. (2009), is a 23-item measure that assesses men’s
knowledge of PrCA (11 items) and colorectal cancer (12
items), including risk factors, signs, symptoms, and screening recommendations for the two diseases. Response
options for all questions were true/false and were scored
by calculating the percentage of correct answers (i.e., 1
point per correct item). The survey was administered to
119 men (72 African Americans, 47 Hispanics) who were
patients at qualified health centers and one hospital-based
primary care clinic in a southern state and reported that
African American men, who were older and had higher
education attainment, had significantly higher PrCA and
colorectal cancer knowledge than Hispanic men. Internal
consistency reliability using Cronbach’s α was 0.75, but
reliability estimates were not reported for each subscale.
Validity information was also not reported.
To assess the impact of a spiritually-based PrCA
informed decision-making intervention, Holt et al. (2009)
developed two scales: the Knowledge of Prostate Cancer
Scale and the Knowledge of the Screening Controversy
Scale. The Knowledge of Prostate Cancer Scale is a nineitem measure that assessed PrCA knowledge and risk factors. The Knowledge of the Screening Controversy Scale
is a four-item measure developed to assess knowledge of
the PrCA screening controversy. One additional, original
item assessed men’s knowledge about the relationship
between PrCA screening and mortality. Scoring was
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determined by calculating the percentage of correct
responses on each scale. In a sample of 49 men, Holt
et al. (2009) discovered that knowledge on the Knowledge
of Prostate Cancer Scale and their one, original item
increased significantly whether the men received a spiritually-based or non-spiritually based education program.
Only men in the spiritually-based intervention (n = 31)
had significant increases on the scale for knowledge of the
screening controversy. Internal consistency reliability for
the Knowledge of Prostate Cancer Scale and Knowledge
of the Screening Controversy Scale using Cronbach’s α
were 0.66 and 0.43, respectively. Scale validity was not
reported.
Ogunsanya et al. (2017) added two items to the
Knowledge of Prostate Cancer Screening Questionnaire
(Weinrich et al., 2004), which expanded it to a 14-item
scale. The two additional items assessed the effects of
diet on PrCA and the screening controversy (i.e., efficacy
of the PSA test). Response categories were true, false,
and I don’t know and scoring was based on the number of
items answered correctly. This 14-item Knowledge of
Prostate Cancer Screening Questionnaire was administered to 267 African American men, aged 18 to 40 years,
to determine the intention of young African American
men to screen for PrCA when it is recommended and relevant correlates. An additional 33 survey items measured
attitudes toward PrCA screening, social influence, comfortability with prostate examinations, cues to action,
health screening experiences, and intention to screen.
African American men had low PrCA knowledge scores
and PrCA knowledge had a positive correlation with
intention to receive PrCA screening. No psychometric
properties on the scale were reported (Ogunsanya et al.,
2017).
Owens et al. (2018) modified Cormier et al.’s (2002)
PrCA Knowledge Scale by adapting it for computer
administration. Items were modified or eliminated if
they were (a) unclear or inconsistent with current screening recommendations or (b) inconsistent with the iDecide PrCA education program, which was developed
based on focus groups with African American men and
educational information from the National Cancer
Institute (National Cancer Institute, 2012; Blinded).
Specifically, the ACS, AUA, and the USPSTF (American
Cancer Society, 2013; Bibbins-Domingo et al., 2017;
Carter et al., 2013) do not support routine screening, but
suggest that men make informed decisions with their
health-care provider based on their PrCA risk. The ACS,
in particular, recommends that African American men, a
high-risk population, begin having conversations about
PrCA screening with their health-care provider at age 45
or as early as age 40 if they have a family history of
PrCA (American Cancer Society, 2013). Items that
referred to routine screening practices or ages that are
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inconsistent with current screening guidelines were
eliminated (see Table 2; Q4, Q12–Q14). Items were
added to clarify the efficacy of PSA and DRE exams,
which included adding that neither are 100% accurate
and neither test can be used to diagnose PrCA because a
PrCA diagnosis is validated via biopsy (see Table 2; Q9,
Q17, Q18). Only the scale by Radosevich et al. (2004)
included items about prostate biopsy to measure knowledge about PrCA screening and diagnosis. One item on
the original scale (see Table 1; Q22) regarding PrCA
warning signs was separated into multiple items and two
questions were added to capture other common symptoms (Table 2; Q23–Q26). Furthermore, an assessment
of face validity resulted in the rewording of two questions (Q1, Q7) to increase clarity. Two additional questions were eliminated based on PrCA subject matter
expert review (Q10, Q11) by the lead author (O.O.) and
two additional PrCA experts with training in health communications. Content validity was assessed by pilot testing the survey containing the PrCA Knowledge Scale
and 45 additional items used to evaluate the iDecide
PrCA screening decision aid. Two African American
men were asked to complete a paper survey, noting if
there were questions, words, or concepts on the survey
that might be difficult to interpret for themselves or men
with low reading levels. After survey completion, they
were also asked verbally by the lead author about these
difficulties following survey completion. Both participants did not suggest additional changes to the survey.
Table 2 presents original and modified versions of the
PrCA Knowledge Scale. Items are scored based on the
percentage of items correct.
In a sample of 352 African American men, the modified 20-item PrCA Knowledge Scale was administered to
evaluate the effectiveness of a computer-based PrCA
screening decision aid, iDecide, to increase PrCA knowledge, informed decision-making self-efficacy, and technology use self-efficacy. iDecide used an African
American embodied conversation agent (i.e., a humanlike character) to guide users thorough the basic information about prostate anatomy and a series of key topics that
one should consider when making informed decisions
about PrCA (e.g., risks and benefits of screening). To reiterate key points during the education session, users were
engaged in question and answer exercises. These
responses were not recorded, but prompted the system to
provide users with the opportunity to choose other
responses until a correct response was selected. Within
the decision aid, users had the control to repeat information, repeat quizzes, and so forth. Following receipt of
basic PrCA education, users were encouraged to participate in short role-play exercise with a second African
American embodied conversational agent who was
dressed like a health-care provider. The goal of this
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section was to prepare the user for a conversation with his
health-care provider. In this section, users had limited
onscreen questions that they could pose to the embodied
conversational agent and it would respond accordingly.
Some questions were included that are commonly asked,
but may not be the best questions to ask in the context of
a PrCA screening discussion. For example, while some
providers may discuss PrCA during a conversation about
an annual check-up, others will not because PrCA screening is not recommended on an annual basis. Therefore, if
a user chose the basic checkup option in iDecide, the
decision aid would inform them why this was not the best
selection and encourage them to choose another option.
The conversation between the user and the embodied
conversation ended when the user indicated that he was
ready to make an informed decision. At this point, the
user was provided with informational resources both
through the decision aid and the research associate. iDecide was about 10 minutes in duration and administered
on a tablet computer. Men received paper-based surveys
prior to and after using iDecide. Overall, PrCA knowledge, informed decision-making self-efficacy, and technology use self-efficacy increased significantly. However,
the psychometric properties of the modified PrCA
Knowledge Scale were not reported (Owens et al., 2018).
Although multiple studies have measured PrCA
knowledge among African American men, most either
do not report psychometric properties of their PrCA
knowledge measure (Abbott et al., 1998; DemarkWahnefried et al., 1993, 1995; Magnus, 2004; Smith
et al., 1997; Steele et al., 2000; Wilkinson et al., 2003),
have low representation of African American men
(Demark-Wahnefried et al., 1993, 1995), or have small
sample sizes (Powe et al., 2009). For the vast majority of
studies reporting the reliability of their PrCA knowledge
measure, internal consistency reliability was consistently
low (i.e., ranging from .45 to .66; Boehm et al., 1995;
Holt et al., 2009; Ogunsanya et al., 2017; Ross et al.,
2011). Two studies reporting moderate to high reliability
(i.e., α = .77, α = .87) among African American men
had small sample sizes and no validity evidence was
reported (Agho & Lewis, 2001; Weinrich et al., 2004).
Agho and Lewis (2001) also used Cronbach’s α instead
of KR-20 to assess internal consistency reliability. The
current study evaluated the psychometric properties of
the modified PrCA Knowledge Scale (Cormier et al.,
2002) in African American men, who have the highest
PrCA mortality risk in the world (Siegel et al., 2019).
Having a reliable and valid measure of PrCA knowledge
is critical for determining whether interventions are
effectively informing African American men about PrCA
screening options, as recommended by the ACS, AUA,
and the USPSTF. See Table 1 for a summary of the
review of measures.
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Knowledge and Attitude
Survey

Scale name

Knowledge of Prostate Cancer
Scale and the Knowledge of
the Screening Controversy
Scale

Knowledge of Prostate Cancer
Screening Questionnaire

Holt et al.
(2009)

Ogunsanya
(2017)

•
•
•
•
•

Multiple choice

13

14

13

23

10

5

20

12

12

PrCA Knowledge

PrCA Knowledge (includes
treatment knowledge)
PrCA Knowledge (includes
treatment knowledge)
PrCA Knowledge

PrCA Knowledge
PrCA Attitudes
PrCA Screening Practices
PrCA Knowledge
Perceived PrCA
knowledge

• PrCA Knowledge
• Knowledge of Screening
Controversy
True/False/ I don’t PrCA Knowledge (includes
know
treatment knowledge)

None reported

• True/False
PrCA Knowledge (includes
• Multiple choice
treatment efficacy and vality
of PSA test)
True/False
• PrCA Knowledge
• Colon Cancer Knowledge

True/False/ I don’t
know
True/False/I don’t
know
True/False/I don’t
know
True/False

True/False

631

PrCA Knowledge

Agree/Disagree

Not
reported

319

PrCA Knowledge

None reported

267

49

119

1152

528

139

835

108

944

556

None
reported
6

PrCA Knowledge

Multiple choice

123

• PrCA Knowledge

7

286

n

• PrCA Knowledge
• PrCA Attitudes

Constructs measured

True/False

Multiple choice

Response options

11

24

#of items

Note. PrCA = prostate cancer; KR-20 = Kuder–Richardson Formula 20.

Cancer Knowledge Survey

Prostate Cancer Knowledge
Scale
PROCASE Knowledge Index

Prostate Cancer Knowledge
Scale
Knowledge of Prostate Cancer
Screening Questionnaire
PrCA Knowledge Scale

Powe et al.
(2009)

Radosevich
et al. (2004)

Wilkinson et al.
(2003)
Weinrich et al.
(2004)
Cormier et al.
(2002)
Magnus

Prostate Cancer Knowledge
Inventory
Prostate Cancer Knowledge
Scale
Prostate Cancer Knowledge
Scale
Knowledge of Prostate Cancer
Screening Questionnaire
PrCA Risks, Knowledge,
Attitudes and Screening
Practices Scale
Agho and Lewis Actual and Perceived Prostate
(2001)
Knowledge Scales

DemarkWahnefried
et al. (1993,
1995)
Boehm et al.
(1995)
Smith et al.
(1997)
Abbott et al.
(1998)
Weinrich et al.
(1998)
Steele et al.
(2000)

Author

Table 1. Review of Prostate Cancer Scales.

None reported

α = .75 for total scale.
None reported for the two
subscales
α = .66 for the PrCA
Knowledge scale and α
= .43 for the Knowledge
of Screening Controversy
Scale
None reported

None reported

None reported

• Criterion
• Construct

Face

• Face
• Construct
None reported

None reported

KR-20 = .68

None reported

None reported

KR-20 = .77

α = .87 for Actual Prostate
Knowledge Scale
α = .81 for Perceived
Prostate Knowledge Scale
None reported

None reported

• Content
• Construct
None reported

A = .73
None reported

None reported

• Content
• Face
None reported

None reported

Validity tested

None reported

KR-20 = .45 and .58 at pre
and posttest
None Reported

None reported

Internal consistency reliability
score

7

Owens et al.
Table 2. Prostate Cancer Knowledge Scale Modifications.
Domain

Text of original questions

Anatomy and 1.
function
2.
Risk factors

3.
4.
5.
6.
7.

8.

Screening

9.
10.
11.
12.
13.
14.

15.

The prostate gland is a small walnut-shaped gland
located below the bladder and connected to the
penis
The prostate gland makes some of the fluid that’s
part of semen
Older men are more likely to get prostate cancer
Any man older than 50 is at risk of prostate cancer*
More African American men are diagnosed with
prostate cancer than Whites
African American men who have fathers or brothers
with prostate cancer are more likely to get prostate
cancer than those who do not
Race is a risk factor for some diseases like high
blood pressure and diabetes. Who do you think is
more likely to get prostate cancer? (White men,
Black men, race is not a factor, Don’t know)**
Who do you think is more likely to get prostate
cancer? (Man whose father has had prostate cancer,
Man whose father has not had prostate cancer, It
doesn’t make any difference, Don’t know)
The only way a man can know if he has prostate
cancer is to have a prostate check-up**
Finding prostate cancer when it has first started to
grow increases the chances of finding a cure*
Finding prostate cancer early can help with the
treatment of cancer*
A man older than 50 should have a rectal check-up
every year*
An examination every 5 years to check for prostate
cancer is the best way to find prostate cancer early*
How often do you think a man older than age 50
should have a rectal check-up (Never, Once every 5
years, One every 3 years, once every 2 years, once a
year, Don’t know).*
A PSA blood test can be done to check for prostate
cancer

16. A man can have prostate cancer and no symptoms
17. The warning signs of prostate cancer are always
present with prostate cancer
Warning signs 19. Pain often in your lower back could be a sign of
prostate cancer.
20. Warning signs for prostate cancer are having a hard
time passing urine; passing urine often, especially
at night; blood or puss in the urine*; and pain or
burning when passing urine*

Text of revised questions
1.

The prostate gland is a reproductive organ
located below the bladder**

2.

The prostate gland makes some of the fluid
that’s part of semen
Older men are more likely to get prostate cancer

3.
4.
5.
6.

7.

More African American men are diagnosed with
prostate cancer than Whites
African American men who have fathers or
brothers with prostate cancer are more likely
to get prostate cancer than those who do not
Who do you think is more likely to get prostate
cancer? (White men, Black men, race is not a
factor, Don’t know)
Who do you think is more likely to get prostate
cancer? (Man whose father has had prostate cancer,
Man whose father has not had prostate cancer, It
doesn’t make any difference, Don’t know)

8.

A PSA blood test can be done to check for
prostate cancer
9. A digital rectal exam or DRE can be done to
check for prostate cancer***
10. The only way a man can know for sure if he has
prostate cancer is to have a prostate biopsy***
11. A prostate biopsy is when a blood test is used
to check for proteins in the blood?***
Neither the PSA nor DRE are 100% accurate.***
13. A man can have prostate cancer and no symptoms
14. The warning signs of prostate cancer are always
present with prostate cancer
15. Pain often in your lower back could be a sign of
prostate cancer.
16. Warning signs of prostate cancer are: having a
hard time passing urine
17. . . .Passing urine often, especially at night
18. . . .Blood in the urine or semen***
19. . . .Painful ejaculation***
20. . . .Pain in the stomach***

Note. PSA = prostate-specific antigen; DRE = digital rectal examination. An * indicates the question was deleted. ** indicates question was
revised. *** denotes that a question was added.
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Conceptual Framework for the
Operationalization of the Prostate
Cancer Knowledge Scale in Informed
PrCA Decision-Making
Social cognitive theory emphasizes the dynamic interplay between individuals, their physical and social environments, and their behaviors (Bandura & Walters, 1977).
In the context of PrCA screening, multiple social and
environmental influences determine whether an individual is able to make an informed decision about PrCA
screening. Two key individual factors that influence
whether an individual has the capacity to engage in
informed decision-making about PrCA screening are
PrCA knowledge and self-efficacy. PrCA knowledge
refers to the information necessary for an individual to
understand PrCA (including the prostate’s anatomy and
function, PrCA risk factors, types of PrCA screening, and
PrCA warning signs) and the risks, benefits, uncertainties
of, and alternatives to PrCA screening (basis of the scale).
Self-efficacy is the level of confidence an individual possesses to actively involve himself, to the extent that he
desires in screening decisions. At the environmental
level, several factors influence whether a man engages in
informed decisions about PrCA screening, but the most
common are access to: PrCA information and a provider.
While the measures reviewed in this manuscript focus on
PrCA knowledge (one construct associated with PrCA
screening decision-making), many of the interventions
that utilize PrCA knowledge measures also work to
enhance a man’s comfort with speaking with a healthcare provider. For example, [Blinded author] sought to
enhance PrCA knowledge and self-efficacy, which is consistent with social cognitive theory.

Methods
This cross-sectional study examined the psychometric
properties of a modified version of the PrCA Knowledge
Scale (Cormier et al., 2002) used in a pretest–posttest
design to evaluate PrCA knowledge before and after the
administration of iDecide, a computer-based decision aid
in African American men. Detailed information about
iDecide is in {Blinded}. Only posttest data are used in the
current study. Human subjects approval was received
from the {Blinded} Institutional Review Board.

Participants
A purposive sample of 352 African American men aged
40 and older were recruited from multiple venues in
South Carolina between July 2015 and February 2016 to
participate in a pilot study. Eligible participants were men
who (a) self-identified as African American; (b) spoke
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and comprehended English; (c) had no personal history
of PrCA; and (d) had no self-reported history of cognitive
decline. All men were provided with study details immediately prior to their study participation through a written
informed consent document. Men were asked to sign the
consent after asking clarifying questions. Detailed study
information is reported in {Blinded}.

Data Analysis
Descriptive statistics were conducted to describe to the
sociodemographic characteristics of the men in the sample. Pearson’s correlation assessed the association
between factors and subscale items. Internal consistency
reliability was assessed using KR-20 for the total scale
and each of the four subscales. KR-20 is an alpha used
when response categories on a measure are dichotomously scored with 1 for correct responses and 0 for
incorrect responses (Waltz et al., 2005).
Exploratory factor analysis (EFA) is a data-driven
exploratory technique and that does not require a priori
specification of the relationships between latent and
observed variables (Brown, 2014; Harrington, 2009;
Kline, 2005). Thus, a priori model specification is not
required because factor structure and factor loadings are
assumed to be unknown. The purpose of EFA is to identify the most parsimonious number of interpretable factors that explain the correlations between observed
variables (Thompson, 2004). In this study, EFA was conducted to identify the number of latent constructs (factors) and underlying factor structure of the modified
PrCA Knowledge Scale. The number of participants to
item ratio is 14:1, which is above the recommended 10:1
often used to determine a priori sample size for EFA
(Costello & Osborne, 2005).
EFA was conducted using weighted least square mean
and variance (WLSMV) estimation with Geomin rotation.
WLSMV is a robust estimator which does not assume normally distributed variables and provides the best option
for modeling categorical or ordered data (Brown, 2014).
The modified PrCA Knowledge Scale (Cormier et al.,
2002) has true/false response categories. Factor structure
was assessed by eigenvalues and proportion of eigenvalues on the scree plot. An eigenvalue greater than one and
the cumulative proportion of eigenvalues of the reduced
covariance matrix greater than one determined if a factor
was retained in the factor structure. A factor with less than
three item loadings was considered weak and unstable
(Costello & Osborne, 2005), and was dropped from the
analysis. Factors with three or more items loading onto
them were retained. Factor loadings were assessed using
item communalities, cross-loadings, and item statistics.
An item was determined to load on a factor if the loading
score was 0.30 or greater (Shultz et al., 2013).
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Table 3. Frequency Distribution of Items for the PrCA Knowledge Scale.
False
Items
Know1
Know2
Know3
Know4
Know5
Know6
Know7
Know8
Know9
Know10
Know11
Know12
Know13
Know14
Know15
Know16
Know17
Know18
Know19
Know20

Description
The prostate gland is a reproductive organ located below the bladder
The prostate gland makes some fluid that is part of semen
Older men are more likely to get prostate cancer
More African American men are diagnosed with prostate cancer than
Whites
African American men who have fathers or brothers with prostate
cancer are more likely to get it
Who do you think is more likely to get prostate cancer
Who do you think is more likely to get prostate cancer
A PSA blood test can be done to check for prostate cancer
A digital rectal examination can be done to check for prostate cancer
The only way a man can know for sure if he has prostate cancer is to
have prostate biopsy
A prostate biopsy is when a blood test is used to check for protein in
the blood
Neither the PSA nor DRE are 100% accurate
A man can have prostate cancer and have no symptoms
The warning signs of prostate cancer are always present
Pain often in your lower back could be assign of prostate cancer
Warning signs of prostate cancer: having hard time passing urine
Passing urine often, especially at night
Blood in the urine or semen
Painful ejaculation
Pain in the stomach

True

N

%

N

%

142
163
70
61

40.34
46.18
19.83
17.33

210
190
283
291

59.66
53.82
80.17
82.67

93

26.42

259

73.58

117
156
51
99
144

33.62
44.96
14.49
28.29
41.14

231
191
301
251
206

66.38
55.04
85.51
71.71
58.86

202

57.71

148

42.29

182
128
293
258
111
134
133
206
247

52.30
36.47
83.95
73.71
31.62
38.40
38.11
58.86
70.77

166
223
56
92
240
215
216
144
102

47.70
63.53
16.05
26.29
68.38
61.60
61.89
41.14
29.23

Note. PrCA = prostate cancer; PSA = prostate-specific antigen; DRE = digital rectal examination.

Cross-loading occurred if an item loaded onto multiple
factors at 0.30 or above.
Fit indices used to assess model fit included the model
chi-square, normed chi-square (χ2/df), root mean square
error of approximation (RMSEA), Bentler’s comparative
fit index (CFI), the standardized root mean square residual (SRMR), and the Tucker–Lewis Index (TLI). Model
fit criteria were a normed chi-square of less than 3,
RMSEA between 0.05 and 0.08 with a confidence interval of less than or equal to 0.05 lower bound and less than
or equal to 0.10 upper bound, CFI greater than or equal to
0.90, SRMR less than 0.10, and TLI greater than or equal
to 0.95 (Kline, 2005). Descriptive statistics, Pearson’s
correlation, and KR-20 were performed using SAS/
STAT®, version 9.4 (SAS Institute, 2015) and EFA was
conducted using Mplus v. 8.2 (Muthén & Muthen, 2017).

Results
The frequency distribution for each item of the modified
PrCA Knowledge Scale is shown in Table 3. An overwhelming majority (85%, n = 301) of African American
men correctly answered that a PSA test can be used to
check for PrCA (Q8) and that African American men are

more often diagnosed with PrCA than Whites (Q4; 83%,
n = 291). The lowest frequencies for incorrectly answered
questions were for Q20, which asked whether warning
signs are always present with PrCA (16%, n = 56) and
Q21, which asked if pain in the lower back is a symptom
of PrCA (26%, n = 92).
Using WLSMV, scree plot and eigenvalues suggested
six factors for the modified 20-item PrCA Knowledge
Scale, but the RMSEA (.03), CFI (.98), TLI (.96), and
SRMR (.06) suggested a five-factor solution may provide
the best fit (Table 4). In the five-factor solution, 20 items
loaded positively on five different factors at 0.30 or above
with factor loadings ranging from 0.34 to 0.94. Three
items (5, 8, 16) cross-loaded. Seven items (1, 2, 5, 8, 9,
12, 13) loaded on PrCA Anatomy and Screening (Factor
1) with item 8 (.34) cross-loading less strongly on Factor
2 and item 5 cross-loading more strongly on Factor 3
(.76). Four items (4, 6, 8, 16) loaded on Probability of
PrCA (Factor 2) with items 8 (.44) and 16 (.68) crossloading more strongly on Factors 1 and 4 respectively.
Three items (3, 5, 7) loaded on Risk Factors (Factor 3)
with item 5 cross-loading less strongly (.32) to Factor 1.
Six items (15, 16, 17, 18, 19, 20) loaded onto Warning
Signs (Factor 4). Two items (11, 14) loaded on PrCA
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350.33 (151)

282.35 (133)

209.90 (116)

144.25
(100)

2 Factors

3 Factors

4 Factors

5 Factors

0.035

0.048

0.056

0.061

0.084

RMSEA

0.98

0.95

0.92

0.90

0.78

CFI

0.96

0.92

0.89

0.87

0.75

TLI

0.06

0.07

0.08

0.10

0.14

SRMR

20-item scale

Q5
Q16

Q8
Q12
Q7
Q8
Q12
Q13
—

—

Crossloadings

—

Q10 (.26)

Q11 (.22)

Q10 (.24)

Q14 (.24)

Item loadings
<.30

110.78
(86)

172.56 (101)

245.52 (117)

316.41 (134)

569.73
(152)

Model chisquare

0.029

0.045

0.056

0.062

0.088

RMSEA

0.99

0.96

0.93

0.90

0.78

CFI

0.97

0.93

0.90

0.87

0.75

TLI

0.05

0.07

0.08

0.10

0.14

SRMR

Q14
Q16
—

Q8
Q12
Q4
Q11

—

Crossloadings

19-item scale

—

—

Q13 (.24)

Q3 (.28)
Q11 (.28)
Q14 (.23)
—

Item loadings
<.30

Note. RMSEA = root mean square error of approximation; CFI = Bentler’s comparative fit index; TLI= Tucker–Lewis index; SRMR = standardized root mean square residual. All model chi-square
estimates were significant at a level of .05. Cutoff criteria for fit indices are as follows: RMSEA <.05, CFI > .90, TLI > .95, SRMR < .08. Cross-loadings occurred if items loaded on two or more
factors at .40 or above.

599.08 (170)

Model chi-square

1 Factor

Models
tested

Fit indices

Table 4. Model Fit for 19 and 20-Item Prostate Cancer Knowledge Scales.
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Diagnosis (Factor 5). Based on the loading pattern, Factor
5 does not have enough items to be considered a subscale
(<3 items; Brown, 2014). Factor 2 also has less than the
three items. In addition, items 4 and 6 (Factor 2) fit better
conceptually with items on Factor 3. Similarly, items 11
and 14 (loaded on Factor 5) fit better conceptually on
Factors 1 and 4, respectively.
Because the fit indices of Factors 1, 2, and 3 were
below standard cutoffs in the five-factor model (Table 4),
a four-factor model was examined, which resulted in better loading patterns and no cross-loadings. Factor loadings ranged from .31 to .86. Seven items (1, 2, 8, 9, 12,
13) loaded on PrCA Anatomy and Screening (Factor 1).
Five items (3, 4, 5, 6, 7) loaded on Risk Factors (Factor
2). Six items (15, 16, 17, 18, 19, and 20) loaded on
Warning Signs (Factor 3). Two items (11, 14) loaded on
PrCA Diagnosis (Factor 4), though items 11 and 14
would fit better conceptually on Factors 1 and 3, respectively. Item 10 did not load onto any factor.

Exploring a 19-Item Factor Structure for the
Prostate Cancer Knowledge Scale
To improve factor structure, item 10 was dropped from
the four-factor model. Item 10 was related to prostate
biopsy, a diagnostic test used to validate whether cancer
is present beyond screening. After item 10 was dropped,
the EFA yielded slightly higher fit indices for the fourand five-factor models on the 19-item PrCA Knowledge
Scale. However, the 19-item, four-factor model had the
best factor loading pattern conceptually. In the four-factor
model, five items (1, 2, 8, 9, 16) loaded on PrCA Anatomy
and Screening (Factor 1), with item 16 cross-loading less
strongly (.32 versus .62) on Factor 3. Five items (3, 4, 5,
6, 7) loaded on Risk Factors (Factor 2). Six items (14, 15,
16, 17, 18, 19, 20) loaded on Warning Signs (Factor 3),
with item 14 loading more strongly (.42 versus .76) on
Factor 4. Two items (11 and 14) loaded on PrCA
Diagnosis (Factor 4). Items 12 and 13 did not load.

Exploring an 18-Item Factor Structure for the
Prostate Cancer Knowledge Scale
Because PrCA Diagnosis (Factor 4) consistently had too
few item loadings to constitute a subscale, two items (11,
14) were considered for removal. Item 11 was removed
because it was the only question remaining that was conceptually related to PrCA diagnosis (i.e., biopsy). Item
14, however, also cross-loaded on Factor 3 (.42), to which
it was more conceptually related so it was retained. Items
12 and 13 were also retained in the 18-item factor structure although they were not in the 19-item factor structure
analyses. Both items loaded (.32 and .41) in the 20-item,

five-factor structure analyses. EFA was re-run with 18
items.
EFA of the 18-item factor structure resulted on 18
items loading onto a factor. While the four- and five-factor models yielded the best fit indices (Table 5), both
models did not have enough items loading onto at least
one factor to constitute a subscale. The three-factor model
had reasonable model fit based on RMSEA (.05), CFI
(.95), and SRMR (.08). For the three-factor model, five
items (1, 2, 5, 7, 8, 9, 12, 13) loaded on PrCA Anatomy
and Screening (Factor 1), with items 5 (.49 versus .56)
and 7 (.39 versus .61) cross-loading more strongly onto
Factor 2. Five items (3, 4, 5, 6, 7) loaded on Risk Factors
(Factor 2), with items 5 and 7 cross-loading on Factor 1.
The remaining seven items (14, 15, 16, 17, 18, 19, 20)
loaded onto Warning Signs (Factor 3) with no cross-loading (Table 6). Each of the three factors were positively
correlated (Table 7) and the total scale had good internal
consistency reliability (KR-20 = .80).

Discussion
Using EFA, this study employed a multi-step process to
determine the most parsimonious and interpretable factor
structure for a modified PrCA Knowledge Scale using
WLSMV estimation. EFA yielded an 18-item, three-factor structure (Anatomy and Screening, Risk Factors, and
Warning Signs) PrCA Knowledge Scale as the best solution for measuring PrCA knowledge among African
American men. This 18-item, three-factor structure is
substantiated by moderate to high (.39–.87) factor loadings, adequate fit indices, a good internal consistency
reliability, and strong conceptual relationships between
items on each subscale. Model estimates and fit indices
were used conjunctively to choose the best overall factor
structure and model fit. Fit indices and scree plots provided the strongest evidence for a five-factor solution, but
an assessment of the factor loading patterns in tandem
with conceptual relationships between items indicated
that a three-factor solution was ideal. All three factors of
the three-factor structure were positively correlated.
Thus, the 18-item, three-factor structure of the PrCA
Knowledge Scale was most parsimonious and conceptually-relevant for measuring PrCA knowledge among
African American men.
The psychometric evidence of the 18-item, three-factor model of the PrCA Knowledge Scale may be greatly
improved compared to evidence on previous versions of
the PrCA Knowledge Scale because of methodological
differences. The current study had a sample of 352
African American men whereas most prior studies had
small samples and subsamples of African American men
ranging from 11 to 123, which resulted in low reliability
estimates or none reported. Studies with larger sample
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Table 5. Factor Loadings for 18-Item Prostate Cancer Knowledge Scale.
Three factors
Items
Know1
Know2
Know3
Know4
Know5
Know6
Know7
Know8
Know9
Know12
Know13
Know14
Know15
Know16
Know17
Know18
Know19
Know20

Fact1

Fact2

Four factors
Fact3

75
87

49
39
40
39
43
64

Fact1

Fact2

Five factors

Fact3

Fact4

Fact1

72
79
32
70
56
65
61

Fact2

Fact3

NL

NL

29
91
62

64

63

63
121

104

36

35
32
NL
34

31

50
68
68
71
75
85
87

Fact5

84
81
31
93

42
37
34
48

Fact4

38
NL

41
64
61
63
72
84
84

NL

82
69
72
69
72
81
80

Note. Cross-loadings occurred if items loaded on two or more factors at .30 or above and are bolded in the table. NL denotes any items that did not load.

Table 6. Model Fit for 18-Item Prostate Cancer Knowledge Scale.
Fit indices
RMSEA

CFI

TFI

SRMR

Cross-loadings

Item loadings <.30

520.09 (135)

0.090

0.79

0.76

0.14

—

2 Factors
3 Factors

268.89 (118)
198.30 (102)

0.060
0.052

0.92
0.95

0.89
0.92

0.09
0.08

4 Factors

130.19 (87)

0.037

0.98

0.96

0.06

5 Factors

81.43 (73)

0.018

0.99

0.99

0.05

Q8
Q5
Q7
Q8
Q14
Q8

Q3 (.29)
Q14 (.20)
—
—

Models tested

Model chi-square

1 Factor

—
Q3 (.29)

Note. RMSEA = root mean square error of approximation; CFI = Bentler’s comparative fit index; SRMR = standardized root mean square
residual. All model chi square estimates were significant at a level of .05. Cutoff criteria for fit indices are as follows: RMSEA < .05, CFI > .90, TLI
> .95, SRMR < .08. Cross-loadings occurred if items loaded on two or more factors at .40 or above.

Table 7. Means, Standard Deviations, Reliabilities, and Pearson Correlations for the Total Scale and Three Subscales of PrCA
Knowledge.
Factors

Mean SD

Total

11.35 4.21

Factor 1

3.79 1.66

Factor 2

Factor 3

3.54 1.43

3.03 2.03

Total

Factor 1

Factor 2

Factor 3

0.56
<.0001

0.81
<.0001

0.80

0.75
<.0001
0.64

0.30
<.0001
0.66

0.43
<.0001
0.22
<.0001
0.75

Note. PrCA = prostate cancer. Kuder–Richardson Formula 20 (KR-20) is the reliability coefficient in the diagonal reported. KR-20 is 0.80
including all items.
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sizes (286–835) reported minimal or no psychometric
evidence. Other PrCA knowledge scales had fewer scale
items, and used various factor analytic methods and internal consistency reliability estimates to assess factors
structure and reliability for a measure with dichotomous
response categories. Factor structure and model fit indices can be sensitive to sample size and number of scale
items, and using inappropriate estimation procedures and
reliability estimates can bias results (Shultz et al., 2013;
Waltz et al., 2005). Overall, this study’s three-factor,
18-item PrCA Knowledge Scale extends prior PrCA psychometric evidence by identifying a measure with more
conceptually-relevant scale items, better domain coverage, and a more parsimonious factor structure that
includes the most recent PrCA screening recommendations. Additional psychometric tests are needed to confirm this factor structure.
To the author’s knowledge, this is the first study to
examine the psychometric properties of a PrCA knowledge
scale that includes recent recommendations from the ACS,
AUA, and the USPSTF, suggesting men make an informed
decision, considering both potential benefits and harms of
screening, with their health-care provider before undergoing PrCA screening. Based on the conceptual framework
guiding this study, men who have lower knowledge of
PrCA (in addition to low decision self-efficacy) may be
less prepared to engage in informed decisions with their
providers about PrCA as recommended by the ACS, AUA,
and the USPSTF. In absence of the informed decisions
about PrCA screening, men could receive later diagnoses
or undergo unnecessary treatment, both of which can lead
to decision regret (Gökce et al., 2017; Orom et al., 2015).
Having a knowledge scale that is culturally appropriate for
African American men can facilitate the evaluation of culturally targeted interventions for educating African
American men about PrCA screening.

(.42 versus .76) onto Factor 3, to which it was conceptually related. Removing Q11 resulted from this item being
the only item loading strongly onto Factor 4.
Both items 10 and 11 asked about prostate biopsy. A
biopsy is a diagnostic test used to diagnose PrCA, unlike
screenings that indicate general abnormalities that could
be attributed to factors other than PrCA. For example, the
PSA screening can be falsely lowered by medications to
treat a swollen prostate or falsely elevated through vigorous physical activity (Cary & Cooperberg, 2013; Smith
et al., 2016). The fact that Q10 and Q11 did not load with
other screening items can potentially be explained by
three rationales: (a) African American men lack biopsy
knowledge, (b) prostate biopsy is not clinically or conceptually related to PrCA screening informed decisionmaking, and (c) question wording lacked clarity. Though
some researchers support the notion that men should be
informed about the potential next steps in the decision
continuum (biopsy, treatment) prior to making a screening decision {Blinded}, most researchers have focused
their interventions on empowering men to make each of
these decisions separately (Ankerst et al., 2012; Ilic et al.,
2015; Violette et al., 2015). Biopsy may not typically be
discussed in conversations about PrCA screening or
included in decision aids about PrCA screening. For
example, Radosevich et al.’s (2004) PROCASE
Knowledge Index was the only scale reviewed that measures biopsy knowledge. Consequently, healthy African
American men’s knowledge about prostate biopsy may
be significantly limited. Further, it is possible, based on
poor performance on Q11 at pre- and post-intervention
(Table 3), that men may have confused the prostate biopsy
and PSA screening procedures. Findings suggest future
research assess prostate biopsy and PSA screening as
independent constructs and prostate biopsy specifically
with more than two scale items.

Dropping Prostate Cancer Biopsy Items

Cross-Loading Items

Item 10 did not load in the 20-item, four-factor structure
of the PrCA Knowledge Scale and was consequently
dropped. Item 10, which reads “The only way for a man
to know for sure if he has PrCA is to have a prostate
biopsy” was expected to load with items on Anatomy and
Screening (Factor 1). By removing item 10, items 11 (“A
prostate biopsy is when a blood test is used to check for
proteins in the blood”) and 14 (“The warning signs are
always present with prostate cancer”) were expected to
load onto Anatomy and Screening (Factor 1) and Warning
Signs (Factor 3), respectively. This new factor loading
pattern eliminated the PrCA Diagnosis (Factor 4), which
did not have enough loadings to constitute a subscale.
However, EFA of the 19-item revealed that Q11 and Q14
still loaded together, but 14 cross-loaded less strongly

Interestingly, Q5 (“African-American men who have
fathers or brothers with prostate cancer are more likely to
get prostate cancer than those who do not”) and Q7
(“Who do you think is more likely to get prostate cancer?. . ...”) both cross-loaded on Anatomy and Screening
(Factor 1) and Risk Factors (Factor 2) with lower loadings on Factor 1. While it is unclear why Q5 cross-loaded
onto Factor 1 (which is conceptually unrelated), Q7
cross-loading onto Factor 1 may be attributed to question
composition. Unlike most questions on the scale which
have true, false, and I don’t know response options, Q7
had four multiple response options (“Man whose father
has had prostate cancer, Man whose father has not had
prostate cancer, It doesn’t make any difference, Don’t
know”) and only 55% of the participants chose correctly.
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Therefore, this multiple-choice option may have increased
the likelihood of response bias.
Study strengths included a large community sample of
African American men, which exceeded the minimum
recommended sample size for EFA (>200; MacCallum
et al., 1999). The African American men were from one
mid-sized city in a southeastern state and may not be generalizable to African American men who reside in other
United States regions or men of younger ages, and other
races and ethnicities. Cross-loadings of two items onto a
factor to which it was conceptually unrelated suggest that
some scale items may need further refinement prior to
future scale administration. Despite these limitations, this
study provides valuable psychometric evidence, which
can contribute to the future development and evaluation
of culturally appropriate interventions to facilitate PrCA
screening decisions of African American men who are at
the highest risk for PrCA mortality. Confirmatory factor
analysis is warranted to confirm convergent and discriminate validity of the PrCA Knowledge Scale.

Conclusion
The robust psychometric evidence on the 18-item, threefactor PrCA Knowledge Scale demonstrates the utility of
this instrument for measuring PrCA knowledge among
African American men, who have the highest mortality
rates nationally. Because current PrCA screening recommendations suggest that men make informed decisions
with their provider about PrCA screening, there is an
emergence of decision aids to enhance men’s PrCA
knowledge. However, there is a lack of evidence-based,
culturally appropriate scales for evaluating the effectiveness of these decision interventions for enhancing knowledge among African American men. Determining whether
African American men are adequately equipped with
knowledge about PrCA screening is critical to ensuring
that they understand the risk, benefits, and uncertainties
of screening; are able to participate in this decision at the
level they desire; and ultimately avoid decision regret.
Furthermore, engaging in PrCA screening decisions early
could ultimately reduce their mortality risk. Therefore,
the PrCA Knowledge Scale shows promise not only for
being instrumental in reliably evaluating decision interventions among African American men, but also in contributing to the elimination of PrCA disparities among
this racial group. The PrCA Knowledge Scale can be used
with any PrCA interventions with African Americans.
Future psychometric testing including confirmatory factor analysis is warranted to confirm convergent and discriminate validity of the PrCA Knowledge Scale. Future
research should also confirm the factor structure of the
PrCA Knowledge Scale using a larger and more demographically diverse sample of African Americans.

American Journal of Men’s Health 
Declaration of Conflicting Interests
The author(s) declared no potential conflicts of interest with
respect to the research, authorship, and/or publication of this
article.

Funding
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was funded by the Office of Vice President
for Research and School of Pharmacy at the University of South
Carolina through an American Cancer Society Institutional
Research Grant (PI: Bennett).

ORCID iD
Otis L. Owens

https://orcid.org/0000-0002-1023-1449

References
Abbott, R. R., Taylor, D. K., & Barber, K. (1998). A comparison
of prostate knowledge of African-American and Caucasian
men: Changes from prescreening baseline to postintervention. The Cancer Journal from Scientific American, 4(3),
175–177.
Agho, A. O., & Lewis, M. A. (2001). Correlates of actual and
perceived knowledge of prostate cancer among African
Americans. Cancer Nursing, 24(3), 165–171.
American Cancer Society. (2013). Prostate cancer: Early detection. Retrieved May 7, 2019, from http://www.cancer.org/
acs/groups/cid/documents/webcontent/003182-pdf.pdf.
Ankerst, D. P., Boeck, A., Freedland, S. J., Thompson, I.
M., Cronin, A. M., Roobol, M. J., Hugosson, J., Stephen
Jones, J., Kattan, M. W., Klein, E. A., Hamdy, F., Neal,
D., Donovan, J., Parekh, D. J., Klocker, H., Horninger, W.,
Benchikh, A., Salama, G., Villers, A., . . . Vickers, A. J.
(2012). Evaluating the PCPT risk calculator in ten international biopsy cohorts: Results from the Prostate Biopsy
Collaborative Group. World Journal of Urology, 30(2),
181–187.
Bandura, A., & Walters, R. H. (1977). Social learning theory
(Vol. 1). Englewood Cliffs, NJ: Prentice-hall.
Barber, K. R., Shaw, R., Folts, M., Taylor, D. K., Ryan, A.,
Hughes, M., Scott, V., & Abbott, R. R. (1998). Differences
between African American and Caucasian men participating in a community-based prostate cancer screening program. Journal of Community Health, 23(6), 441–451.
Bibbins-Domingo, K., Grossman, D. C., & Curry, S. J. (2017).
The US Preventive Services Task Force 2017 draft recommendation statement on screening for prostate cancer: An
invitation to review and comment. JAMA, 317(19), 1949–
1950.
Boehm, S., Coleman-Burns, P., Schlenk, E. A., Funnell, M. M.,
Parzuchowski, J., & Powell, I. J. (1995). Prostate cancer
in African American men: Increasing knowledge and selfefficacy. Journal of Community Health Nursing, 12(3),
161–169.
Briss, P., Rimer, B., Reilley, B., Coates, R. C., Lee, N. C.,
Mullen, P., Corso, P., Hutchinsonm, A. B., Hiatt, R.,
Kerner, J., George, P., White, C., Gandhi, N., Saraiya,

Owens et al.
M., Breslow, R., Isham, G., Teutsch, S. M., Hinman, A.
R., & Lawrence, R; Task Force on Community Preventive
Services. (2004). Promoting informed decisions about
cancer screening in communities and healthcare systems.
American Journal of Preventive Medicine, 26(1), 67–80.
Brown, T. A. (2014). Confirmatory factor analysis for applied
research. New York, NY: The Guilford Press.
Carter, H. B., Albertsen, P. C., Barry, M. J., Etzioni, R.,
Freedland, S. J., Greene, K. L., Holmberg, L., Kantoff, P.,
Konety, B. R., Murad, M. H., Penson, D. F., & Zietman, A.
L. (2013). Early detection of prostate cancer: AUA guideline. The Journal of Urology, 190(2), 419–426.
Cary, K. C., & Cooperberg, M. R. (2013). Biomarkers in prostate cancer surveillance and screening: Past, present, and
future. Therapeutic Advances in Urology, 5(6), 318–329.
Cormier, L., Kwan, L., Reid, K., & Litwin, M. S. (2002).
Knowledge and beliefs among brothers and sons of men
with prostate cancer. Urology, 59(6), 895–900.
Costello, A. B., & Osborne, J. (2005). Practical assessment, research & evaluation. The Journal of Consumer
Marketing, 10(7), 1–9.
Demark-Wahnefried, W., Catoe, K., Paskett, E., Robertson, C.,
& Rimer, B. (1993). Characteristics of men reporting for
prostate cancer screening. Urology, 42(3), 269–274.
Demark-Wahnefried, W., Strigo, T., Catoe, K., Conaway, M.,
Brunetti, M., Rimer, B. K., & Robertson, C. N. (1995).
Knowledge, beliefs, and prior screening behavior among
blacks and whites reporting for prostate cancer screening.
Urology, 46(3), 346–351.
Dhillon, P., Grivas, P., Raska, P., Hickman, D., Elson, P.,
Awadalla, A., Abraham, J., Smolenski, K. N., Zhu, H.,
Schalcosky, T., Modlin, C., Bell, K., . . . Abraksia, S.
(2017). Informed decision making for prostate cancer
screening in a high-risk population. Journal of Clinical
Oncology, 35(6_suppl), 112–112.
Fleshner, K., Carlsson, S., & Roobol, M. (2017). The effect
of the USPSTF PSA screening recommendation on prostate cancer incidence patterns in the USA. Nature Reviews
Urology, 14(1), 26.
Gibson, L., Tan, A. S., Freres, D., Lewis, N., Martinez, L.,
& Hornik, R. C. (2016). Nonmedical information seeking amid conflicting health information: Negative and
positive effects on prostate cancer screening. Health
Communication, 31(4), 417–424.
Gökce, M. I., Wang, X., Frost, J., Roberson, P., Volk, R. J.,
Brooks, D., Canfeld, S. C., & Pettaway, C. A. (2017).
Informed decision making before prostate-specific antigen screening: Initial results using the American Cancer
Society decision aid among medically underserved men.
Cancer, 123(4), 583–591.
Harrington, D. (2009). Confirmatory factor analysis. Oxford
University Press.
Holt, C., Wynn, T. A., Litaker, M. S., Southward, P., Jeames,
S. E., & Schulz, E. K. (2009). A comparison of a spiritually based and non-spiritually based educational intervention
for informed decision making for prostate cancer screening
among church-attending African-American men. Urologic
Nursing, 29(4), 249.

15
Ilic, D., Jammal, W., Chiarelli, P., Gardiner, R. A., Hughes,
S., Stefanovic, D., & Chambers, S. K. (2015). Assessing
the effectiveness of decision aids for decision making in
prostate cancer testing: A systematic review. Psycho
Oncology, 24(10), 1303–1315.
Kim, E. H., & Andriole, G. L. (2015). Prostate-specific antigen-based screening: Controversy and guidelines. BMC
Medicine, 13(1), 61.
Kline, R. (2005). Principles and practice of structural equation
modeling (2nd ed.). Guilford Press.
MacCallum, R. C., Widaman, K. F., Zhang, S., & Hong, S.
(1999). Sample size in factor analysis. Psychological
Methods, 4(1), 84.
Magnus, M. (2004). Prostate cancer knowledge among multiethnic black men. Journal of the National Medical
Association, 96(5), 650.
Mordukhovich, I., Reiter, P. L., Backes, D. M., Family, L.,
McCullough, L. E., O’Brien, K. M., Razzaghi, H., &
Olshan, A. F. (2011). A review of African American-White
differences in risk factors for cancer: Prostate cancer.
Cancer Causes & Control, 22(3), 341–357.
Mullen, P. D., Allen, J. D., Glanz, K., Fernandez, M. E., Bowen,
D. J., Pruitt, S. L., Glenn, B. A., & Pignone, M. (2006).
Measures used in studies of informed decision making
about cancer screening: A systematic review. Annals of
Behavioral Medicine, 32(3), 188–201.
Muthén, L. K., & Muthen, B. (2017). Mplus User’s Guide:
Statistical Analysis with Latent Variables, User’s Guide.
National Cancer Institute. (2012). What you need to know about
prostate cancer. Retrieved May 7, 2019, from https://www.
cancer.gov/publications/patient-education/prostate.pdf on.
Ogunsanya, M., Brown, C. M., Odedina, F. T., Barner, J. C., &
Adedipe, T. (2017). Determinants of prostate cancer screening
intentions of young black men aged 18 to 40 years. Journal of
Racial and Ethnic Health Disparities, 4(5), 1009–1020.
Orom, H., Underwood, W., III, Homish, D. L., Kiviniemi, M.
T., Homish, G. G., Nelson, C. J., & Schiffman, Z. (2015).
Prostate cancer survivors’ beliefs about screening and treatment decision-making experiences in an era of controversy.
Psycho-Oncology, 24(9), 1073–1079.
Owens, O. L., Felder, T., Tavakoli, A. S., Revels, A. A.,
Friedman, D. B., Hughes-Halbert, C., & Hébert, J. R.
(2018). Evaluation of a computer-based decision aid for
promoting informed prostate cancer screening decisions
among African American men: iDecide. American Journal
of Health Promotion, 33(2), 267–278.
Powe, B., Cooper, D. L., Harmond, L., Ross, L., Mercado, F.
E., & Faulkenberry, R. (2009). Comparing knowledge of
colorectal and prostate cancer among African American
and Hispanic men. Cancer Nursing, 32(5), 412–417.
Radosevich, D., Partin, M. R., Nugent, S., Nelson, D., Flood,
A. B., Holtzman, J., Dillon, N., Haas, M., & Wilt, T. J.
(2004). Measuring patient knowledge of the risks and benefits of prostate cancer screening. Patient Education and
Counseling, 54(2), 143–152.
Riikonen, J., Guyatt, G., Kilpeläinen, T., Craigie, S., Agarwal,
A., Agoritsas, T., Couban, R., Dahm, P., Järvinen, P.,
Montori, V., Power, N., Richard, P. O., Rutanen, J., Santti,

16
H., Tailly, T., Violette, P. D., Zhou, Q., & Tikkinen, K. A..
(2018). Decision aids for prostate cancer screening choice:
A systematic review and meta-analysis. European Urology
Supplements, 17(2), e381–e382.
Ross, L., Dark, T., Orom, H., Underwood, W., Anderson-Lewis,
C., Johnson, J., & Erwin, D. O. (2011). Patterns of information behavior and prostate cancer knowledge among
African–American men. Journal of Cancer Education,
26(4), 708–716.
SAS Institute. (2015). Base SAS 9.4 Procedures Guide. SAS
Institute.
Shultz, K., Whitney, D., & Zickar, M. (2013). Measurement
theory in action: Case studies and exercises: Routledge.
Siegel, R. L., Miller, K. D., & Jemal, A. (2019). Cancer statistics, 2019. CA: A Cancer Journal for Clinicians, 69(1),
7–34.
Smith, G., DeHaven, M. J., Grundig, J. P., & Wilson, G. R.
(1997). African-American males and prostate cancer:
Assessing knowledge levels in the community. Journal of
the National Medical Association, 89(6), 387–391.
Smith, R. A., Andrews, K., Brooks, D., DeSantis, C. E., Fedewa,
S. A., Lortet-Tieulent, J., Manassaram-Baptiste, D., Brawley,
O. W., & Wender, R. C. (2016). Cancer screening in the
United States, 2016: A review of current American Cancer
Society guidelines and current issues in cancer screening.
CA: A Cancer Journal for Clinicians, 66(2), 95–114.
Steele, C., Miller, D., Maylahn, C., Uhler, R. J., & Baker, C.
T. (2000). Knowledge, attitudes, and screening practices
among older men regarding prostate cancer. American
Journal of Public Health, 90(10), 1595.
Taksler, G., Keating, N., & Cutler, D. (2012). Explaining racial
differences in prostate cancer mortality. Cancer, 118(17),
4280–4289.

American Journal of Men’s Health 
Ukoli, F., Patel, K., Hargreaves, M., Beard, K., Moton, P.
J., Bragg, R., Beech, D., & Davis, R. (2013). A tailored
prostate cancer education intervention for low-income
African Americans: Impact on knowledge and screening.
Journal of Health Care for the Poor and Underserved,
24(1), 311–331.
Violette, P. D., Agoritsas, T., Alexander, P., Riikonen, J.,
Santti, H., Agarwal, A., Bhatnagar, N., Dahm, P., Montori,
V., Guyatt, G. H., & Tikkinen, K. A. (2015). Decision aids
for localized prostate cancer treatment choice: Systematic
review and meta-analysis. CA: A Cancer Journal for
Clinicians, 65(3), 239–251.
Waltz, C., Strickland, O., & Lenz, E. (2005). Measurement in
nursing and health research (3rd ed.). Springer Publishing
Company.
Weinrich, S., Seger, R., Miller, B., Davis, C., Kim, S., Wheeler,
C., & Weinrich, M. (2004). Knowledge of the limitations
associated with prostate cancer screening among lowincome men. Cancer Nursing, 27(6), 442–451.
Weinrich, S. P., Weinrich, M. C., Boyd, M. D., & Atkinson, C.
(1998). The impact of prostate cancer knowledge on cancer
screening. Oncology Nursing Forum, 25(3), 527–534.
Wilkinson, S., List, M., Sinner, M., Dai, L., & Chodak, G.
(2003). Educating African-American men about prostate
cancer: Impact on awareness and knowledge. Urology,
61(2), 308–313.
Wolf, A. M., Wender, R. C., Etzioni, R. B., Thompson, I.
M., D’Amico, A. V., Volk, R. J., Brooks, D. D., Dash,
C., Guessous, I., Andrews, K., DeSantis, C., & Smith, R.
A; American Cancer Society Prostate Cancer Advisory
Committee. (2010). American Cancer Society guideline for
the early detection of prostate cancer: Update 2010. CA: A
Cancer Journal for Clinicians, 60(2), 70–98.

